J. Goldman & Co LP - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,676,133
-27.9%
758,431
-17.2%
0.06%
-35.1%
Q1 2023$2,325,373
+2368.5%
915,501
+1717.4%
0.09%
+1780.0%
Q4 2022$94,201
-92.0%
50,375
-89.0%
0.01%
-91.1%
Q3 2022$1,180,000
+2925.6%
459,000
+2155.2%
0.06%
+2700.0%
Q2 2022$39,000
-98.8%
20,353
-98.1%
0.00%
-98.6%
Q1 2022$3,138,000
+621.4%
1,056,631
+1167.9%
0.14%
+429.6%
Q2 2020$435,000
-26.4%
83,334
-55.6%
0.03%
-62.0%
Q1 2020$591,000
+46.7%
187,755
+87.8%
0.07%
+144.8%
Q4 2019$403,000
-41.2%
100,000
-37.0%
0.03%
-43.1%
Q3 2019$685,000158,6500.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders